This is the KEY you missed Pal
Fletcher, a 59-year-old Perth resident who works in the financial industry, was able to access Recce’s R327 compound last year under Australia’s Special Access Scheme, a pathway for unapproved medicine used to treat potentially deadly conditions.
So this treatment was done last year, this date precedes the testing we believe to be happening on burns trials at the moment.
I hope this helps
RED
- Forums
- ASX - By Stock
- Ann: Positive Sinusitis Patient Update - Special Access Scheme
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.23%
!
30.0¢

This is the KEY you missed PalFletcher, a 59-year-old Perth...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
-0.010(3.23%) |
Mkt cap ! $86.51M |
Open | High | Low | Value | Volume |
30.5¢ | 32.0¢ | 29.5¢ | $30.88K | 101.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21103 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 21103 | 0.300 |
4 | 126250 | 0.295 |
1 | 9274 | 0.290 |
3 | 113518 | 0.285 |
11 | 291389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 15000 | 1 |
0.330 | 139230 | 2 |
0.350 | 31000 | 3 |
0.375 | 8002 | 1 |
0.380 | 6820 | 2 |
Last trade - 15.59pm 26/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online